Universal Biosensors surges 60% on FDA approval for Class II device
Universal Biosensors shares surged 60% following the attainment of US Food and Drug Administration and Clinical Laboratory Improvement Amendments Waiver approvals.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
WFM | as of 07/12/12 new code is adj | 15/12/12 | 2 | 1.5K | |||
|
|||||||
WFM | Ann: Change of Name to Adslot Ltd | 04/12/12 | 0 | 789 | |||
|
|||||||
WFM | Ann: Change of Director's Interest Notice - B | 28/11/12 | 0 | 573 | |||
|
|||||||
WFM | Ann: Change of Director's Interest Notice - G | 28/11/12 | 0 | 575 | |||
|
|||||||
WFM | Ann: Appendix 3B | 27/11/12 | 0 | 673 | |||
|
|||||||
WFM | Ann: Results of 2012 Annual General Meeting | 27/11/12 | 0 | 652 | |||
|
|||||||
WFM | Ann: Chief Executive's Address to Shareholder | 27/11/12 | 0 | 398 | |||
|
|||||||
WFM | Ann: Chairman's Address to Shareholders | 27/11/12 | 0 | 489 | |||
|
See All Discussions